Clinical Studies Search

Protocol Summary


Protocol No.
PSCI-17-070
Prinicipal Investigator
Aregawi, Dawit
Phase
Phase II
Age Group
Adult
Scope
National
Secondary Protocol No.
ML29496, OHSU eIRB11601
Title
Maintenance Obinutuzumab for Primary Central Nervous System Lymphoma Complete Responders
Objective
To determine the effect of maintenance obinutuzumab on duration of complete response (CR) in
patients with CD20+B-cell PCNSL who attain CR to first-line treatment with high-dose methotrexate-based chemotherapy.
Applicable Disease Sites
Brain and Nervous System
Status
Open
Participating Institutions
Hershey Medical Center